Furthermore, nanoparticles carrying specific siRNA targeting GLUT3 inhibited cell metabolism and the proliferation of glioma stem and bulk cells and inhibited tumor growth in the U87MG xenograft model [12]. The gene discussed is SLC2A3; the disease is neoplasm.